SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-055098
Filing Date
2021-09-08
Accepted
2021-09-08 07:00:08
Documents
1
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4368
  Complete submission text file 0001209191-21-055098.txt   5789
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXICURE, INC. 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address
Papadimas Elias D. (Reporting) CIK: 0001865732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39011 | Film No.: 211240622